1,064 filings
Page 36 of 54
DEF 14A
EYPT
EyePoint Pharmaceuticals Inc
Definitive proxy
25 Oct 12
12:00am
PRE 14A
EYPT
EyePoint Pharmaceuticals Inc
Preliminary proxy
2 Oct 12
12:00am
10-K
2012 FY
EYPT
EyePoint Pharmaceuticals Inc
Annual report
27 Sep 12
12:00am
8-K
EYPT
EyePoint Pharmaceuticals Inc
24 Sep 12
Psivida Corp. Reports Fourth Quarter
12:00am
424B5
EYPT
EyePoint Pharmaceuticals Inc
2 Aug 12
Prospectus supplement for primary offering
12:00am
8-K
EYPT
EyePoint Pharmaceuticals Inc
2 Aug 12
Other Events
12:00am
8-K
EYPT
EyePoint Pharmaceuticals Inc
1 Aug 12
Other Events
12:00am
8-K
EYPT
EyePoint Pharmaceuticals Inc
19 Jul 12
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
EYPT
EyePoint Pharmaceuticals Inc
18 Jul 12
Other Events
12:00am
10-Q
2012 Q3
EYPT
EyePoint Pharmaceuticals Inc
Quarterly report
10 May 12
12:00am
8-K
EYPT
EyePoint Pharmaceuticals Inc
9 May 12
Psivida Corp. Reports Results for the Third Quarter
12:00am
8-K
EYPT
EyePoint Pharmaceuticals Inc
27 Mar 12
Other Events
12:00am
8-K
EYPT
EyePoint Pharmaceuticals Inc
6 Mar 12
Departure of Directors or Certain Officers
12:00am
8-K
EYPT
EyePoint Pharmaceuticals Inc
28 Feb 12
ILUVIEN expected to be indicated for chronic DME considered insufficiently responsive to available therapies
12:00am
10-Q
2012 Q2
EYPT
EyePoint Pharmaceuticals Inc
Quarterly report
9 Feb 12
12:00am
8-K
EYPT
EyePoint Pharmaceuticals Inc
8 Feb 12
Psivida Corp. Reports Results for the Second Quarter
12:00am
CT ORDER
EYPT
EyePoint Pharmaceuticals Inc
8 Feb 12
Confidential treatment order
12:00am
10-K/A
2011 FY
EYPT
EyePoint Pharmaceuticals Inc
Annual report (amended)
27 Dec 11
12:00am
8-K
EYPT
EyePoint Pharmaceuticals Inc
2 Dec 11
Submission of Matters to a Vote of Security Holders
12:00am
8-K
EYPT
EyePoint Pharmaceuticals Inc
14 Nov 11
Psivida Reports Receipt by Alimera Sciences of Complete Response Letter from Fda for IluvienĀ® for Dme
12:00am